This sounds even better than the nose cells!
http://www.qthera.com/
Every year, millions of people suffer from
debilitating diseases of the central nervous
system (CNS) that traditional pharmaceutical and
biotechnology products cannot repair. Q
Therapeutics is working to address this medical
challenge with new cellular products intended
to restore normal function in damaged nervous
system tissues. Our first product, Q-CellsĀ, is
designed to replace myelin on injured neurons.
Our initial focus includes testing in transverse
myelitis and use of Q-Cells as a unique drug
screening tool to identify follow-on
pharmaceutical products.
Q-Cells will target treatment of demyelinating
diseases such as transverse myelitis, multiple
sclerosis (MS), and potentially certain traumatic
spinal cord injuries. Q-Cell products may also
be developed to address other diseases, including
cerebral palsy, stroke, amyotrophic lateral
sclerosis (ALS, or Lou Gehrig's Disease), and
Parkinson's Disease.
Additionally, Q-Cells will be used for screening
to expedite development of follow-on
pharmaceutical products. By incorporating Q
Therapeutics' cells in the screening and
development process, companies can test their
therapeutic candidates in the living cells that
generate the entire central nervous system.
Q-Cells will be manufactured at the University of
Utah's Cell Therapy Facility, in accordance with
FDA requirements. The product will then be
shipped to specialty neurology centers as an
off-the-shelf cell therapy.
* In models of human disease, Q-Cells can repair damaged neurons.
* In these disease models, Q-Cells
act locally within the central nervous system,
following endogenous cues to mimic what occurs
normally.
* By following their genetic
programming, Q-Cells use natural processes to
remyelinate damaged neurons.
* No abnormal effects have been
observed in studies involving Q-Cells.
Akua
--
http://www.healrecover.blogspot.com
http://www.akualezli.blogspot.com
